Efpia Strategic Research Agenda for Innovative Medicines Initiative 2 (IMI2)
Making the EFPIA Physicians Spend Numbers Talk - See What the Spend Data May be Telling Us
-
Upload
qordata -
Category
Health & Medicine
-
view
83 -
download
0
Transcript of Making the EFPIA Physicians Spend Numbers Talk - See What the Spend Data May be Telling Us
![Page 1: Making the EFPIA Physicians Spend Numbers Talk - See What the Spend Data May be Telling Us](https://reader035.fdocuments.us/reader035/viewer/2022062523/58edcf011a28ab8b538b45a7/html5/thumbnails/1.jpg)
Making the EFPIA Physicians Spend Numbers Talk!
See what the spend data may be telling us.
![Page 2: Making the EFPIA Physicians Spend Numbers Talk - See What the Spend Data May be Telling Us](https://reader035.fdocuments.us/reader035/viewer/2022062523/58edcf011a28ab8b538b45a7/html5/thumbnails/2.jpg)
1 – Summary of Numbers from 2015 EFPIA disclosure2 – What the numbers may tell us if we look closer3 – EU wide analytics – case study 13 – Country wide analytics – case study 24 – Company wide analytics – case study 35 – Business and compliance considerations6 – Q & A
Agenda:
![Page 3: Making the EFPIA Physicians Spend Numbers Talk - See What the Spend Data May be Telling Us](https://reader035.fdocuments.us/reader035/viewer/2022062523/58edcf011a28ab8b538b45a7/html5/thumbnails/3.jpg)
Summary of Numbers from 2015 EFPIA dataThe EFPIA transparency directive received its first data set in June of 2015, some 3 months ago. During this time press has questioned the rates of consent received from physicians in reporting spend details, and questioned if the program met its objective.
We will present many numbers – you draw your own conclusions…
![Page 4: Making the EFPIA Physicians Spend Numbers Talk - See What the Spend Data May be Telling Us](https://reader035.fdocuments.us/reader035/viewer/2022062523/58edcf011a28ab8b538b45a7/html5/thumbnails/4.jpg)
One view of consent ratio’s
35%
65%
![Page 5: Making the EFPIA Physicians Spend Numbers Talk - See What the Spend Data May be Telling Us](https://reader035.fdocuments.us/reader035/viewer/2022062523/58edcf011a28ab8b538b45a7/html5/thumbnails/5.jpg)
Summary of Numbers from 2015 EFPIA data• The national press has reported that in in UK a total
spend of £300+ M were reported where 70% of physicians consented to have their data included. • In Germany 20,000 of the 71,000 reportable
physicians consented. With data disclosed by 54 companies that represent 75% of the market.• We found that the ratio’s may be lower.
![Page 6: Making the EFPIA Physicians Spend Numbers Talk - See What the Spend Data May be Telling Us](https://reader035.fdocuments.us/reader035/viewer/2022062523/58edcf011a28ab8b538b45a7/html5/thumbnails/6.jpg)
What the numbers may be telling us if we look closerAverages and generalizations are convenient but they may not reveal the true color of disclosure.
Three case studies:
EU wide Country wide (Germany)Company wide (masked)
![Page 7: Making the EFPIA Physicians Spend Numbers Talk - See What the Spend Data May be Telling Us](https://reader035.fdocuments.us/reader035/viewer/2022062523/58edcf011a28ab8b538b45a7/html5/thumbnails/7.jpg)
EU wide analytics – case study 1EU wide data restricted to 4 countries for ease of sharing:GermanySpainItalyUK
![Page 8: Making the EFPIA Physicians Spend Numbers Talk - See What the Spend Data May be Telling Us](https://reader035.fdocuments.us/reader035/viewer/2022062523/58edcf011a28ab8b538b45a7/html5/thumbnails/8.jpg)
EU wide analytics – case study 1At the national level across countries – the ratio’s and spend priorities begin to tell a story where spend patterns may show a regional focus.
Here is are several snapshots by spend type:
![Page 9: Making the EFPIA Physicians Spend Numbers Talk - See What the Spend Data May be Telling Us](https://reader035.fdocuments.us/reader035/viewer/2022062523/58edcf011a28ab8b538b45a7/html5/thumbnails/9.jpg)
Total Spend: Germany has the largest spend EURO 576M
![Page 10: Making the EFPIA Physicians Spend Numbers Talk - See What the Spend Data May be Telling Us](https://reader035.fdocuments.us/reader035/viewer/2022062523/58edcf011a28ab8b538b45a7/html5/thumbnails/10.jpg)
Donations & Grants: UK has the largest spend EURO 25MDonations & Grants: Germany has the lowest spend EURO 8M
![Page 11: Making the EFPIA Physicians Spend Numbers Talk - See What the Spend Data May be Telling Us](https://reader035.fdocuments.us/reader035/viewer/2022062523/58edcf011a28ab8b538b45a7/html5/thumbnails/11.jpg)
Fees: Spain has the largest spend EURO 297MFees: UK has the lowest spend EURO 34M
![Page 12: Making the EFPIA Physicians Spend Numbers Talk - See What the Spend Data May be Telling Us](https://reader035.fdocuments.us/reader035/viewer/2022062523/58edcf011a28ab8b538b45a7/html5/thumbnails/12.jpg)
Registration Fees: Italy has the largest spend EURO 24MRegistration Fees: UK has the lowest spend EURO 3M
![Page 13: Making the EFPIA Physicians Spend Numbers Talk - See What the Spend Data May be Telling Us](https://reader035.fdocuments.us/reader035/viewer/2022062523/58edcf011a28ab8b538b45a7/html5/thumbnails/13.jpg)
Country wide analytics – case study 2Germany – der Spiegel’s analysis claims that:• 75% of pharmaceutical industry drug manufacturers reported
25% of spend data not reported • *20,000 out of 70,000 physicians (33%) consented
66% of physician level spend not reported
qordata noted that the transparency in Germany was “about” 7% and not 33%.
Here are the numbers qordata’s analytics engine offered.
* of those who reported
![Page 14: Making the EFPIA Physicians Spend Numbers Talk - See What the Spend Data May be Telling Us](https://reader035.fdocuments.us/reader035/viewer/2022062523/58edcf011a28ab8b538b45a7/html5/thumbnails/14.jpg)
![Page 15: Making the EFPIA Physicians Spend Numbers Talk - See What the Spend Data May be Telling Us](https://reader035.fdocuments.us/reader035/viewer/2022062523/58edcf011a28ab8b538b45a7/html5/thumbnails/15.jpg)
![Page 16: Making the EFPIA Physicians Spend Numbers Talk - See What the Spend Data May be Telling Us](https://reader035.fdocuments.us/reader035/viewer/2022062523/58edcf011a28ab8b538b45a7/html5/thumbnails/16.jpg)
![Page 17: Making the EFPIA Physicians Spend Numbers Talk - See What the Spend Data May be Telling Us](https://reader035.fdocuments.us/reader035/viewer/2022062523/58edcf011a28ab8b538b45a7/html5/thumbnails/17.jpg)
575M 20,000
![Page 18: Making the EFPIA Physicians Spend Numbers Talk - See What the Spend Data May be Telling Us](https://reader035.fdocuments.us/reader035/viewer/2022062523/58edcf011a28ab8b538b45a7/html5/thumbnails/18.jpg)
Changing the criteria for consent ratio• Criteria: Level of visibility into spend as the bases for evaluating the
affect of consent.
• Formula: Total amount of spend (for consented physicians) /Total amount of General spend (consented + non consented)*Research payments excluded from the formula
Result:
![Page 19: Making the EFPIA Physicians Spend Numbers Talk - See What the Spend Data May be Telling Us](https://reader035.fdocuments.us/reader035/viewer/2022062523/58edcf011a28ab8b538b45a7/html5/thumbnails/19.jpg)
CalculationCompany Name Consent Amount Non Consent Amount Consent %Alexion 0.00 € 756,814.00 € 0.00%Seqirus GmbH 0.00 € 7,125.00 € 0.00%Aegerion Pharmaceuticals GmbH 1,653.40 € 0.00 € 100.00%MediGene AG 34,033.77 € 1,943.60 € 94.60%Baxter Deutschland GmbH 38,097.74 € 161,070.81 € 19.13%Eisai GmbH 39,453.59 € 214,496.26 € 15.54%GlaxoSmithKline GmbH & Co. KG 130,649.08 € 266,433.34 € 32.90%Lundbeck GmbH 189,041.12 € 809,967.23 € 18.92%Shire 218,132.01 € 878,083.34 € 19.90%Roche Pharma AG 252,433.83 € 2,692,411.98 € 8.57%ACTELION Pharmaceuticals Deutschland GmbH 269,632.02 € 620,066.39 € 30.31%
MSD SHARP & DOHME GmbH 1,978,646.18 € 4,672,909.29 € 29.75%Berlin-Chemie AG 2,106,647.64 € 5,824,356.26 € 26.56%Novartis Pharma GmbH 3,570,612.08 € 8,605,871.45 € 29.32%
23,099,253.78 € 257,848,556.46 € 29.57%
----------------------------------- ----- ------- --
Aggregated Consent %:
23,099,253.78 € /257,848,556.46 € =
0.089584577 or 9%
75% of pharmaceutical industry drug manufacturers reported
25% of spend data not reported
Absolute Consent %:
75% of 9% =0.067188433 or 6.7%
![Page 20: Making the EFPIA Physicians Spend Numbers Talk - See What the Spend Data May be Telling Us](https://reader035.fdocuments.us/reader035/viewer/2022062523/58edcf011a28ab8b538b45a7/html5/thumbnails/20.jpg)
Germany
![Page 21: Making the EFPIA Physicians Spend Numbers Talk - See What the Spend Data May be Telling Us](https://reader035.fdocuments.us/reader035/viewer/2022062523/58edcf011a28ab8b538b45a7/html5/thumbnails/21.jpg)
Italy
![Page 22: Making the EFPIA Physicians Spend Numbers Talk - See What the Spend Data May be Telling Us](https://reader035.fdocuments.us/reader035/viewer/2022062523/58edcf011a28ab8b538b45a7/html5/thumbnails/22.jpg)
Der SpiegelAny volunteers willing to contact the newspaper and help enlighten them?
![Page 23: Making the EFPIA Physicians Spend Numbers Talk - See What the Spend Data May be Telling Us](https://reader035.fdocuments.us/reader035/viewer/2022062523/58edcf011a28ab8b538b45a7/html5/thumbnails/23.jpg)
Company wide analytics – case study 3Company name masked – main idea is to illustrate how data analytics can help know the full story and gain insight.
![Page 24: Making the EFPIA Physicians Spend Numbers Talk - See What the Spend Data May be Telling Us](https://reader035.fdocuments.us/reader035/viewer/2022062523/58edcf011a28ab8b538b45a7/html5/thumbnails/24.jpg)
![Page 25: Making the EFPIA Physicians Spend Numbers Talk - See What the Spend Data May be Telling Us](https://reader035.fdocuments.us/reader035/viewer/2022062523/58edcf011a28ab8b538b45a7/html5/thumbnails/25.jpg)
Is the regional spend, spend ratios & TOV amount in line …
![Page 26: Making the EFPIA Physicians Spend Numbers Talk - See What the Spend Data May be Telling Us](https://reader035.fdocuments.us/reader035/viewer/2022062523/58edcf011a28ab8b538b45a7/html5/thumbnails/26.jpg)
Ability to evaluate influences…
![Page 27: Making the EFPIA Physicians Spend Numbers Talk - See What the Spend Data May be Telling Us](https://reader035.fdocuments.us/reader035/viewer/2022062523/58edcf011a28ab8b538b45a7/html5/thumbnails/27.jpg)
![Page 28: Making the EFPIA Physicians Spend Numbers Talk - See What the Spend Data May be Telling Us](https://reader035.fdocuments.us/reader035/viewer/2022062523/58edcf011a28ab8b538b45a7/html5/thumbnails/28.jpg)
HCO Analysis …
![Page 29: Making the EFPIA Physicians Spend Numbers Talk - See What the Spend Data May be Telling Us](https://reader035.fdocuments.us/reader035/viewer/2022062523/58edcf011a28ab8b538b45a7/html5/thumbnails/29.jpg)
![Page 30: Making the EFPIA Physicians Spend Numbers Talk - See What the Spend Data May be Telling Us](https://reader035.fdocuments.us/reader035/viewer/2022062523/58edcf011a28ab8b538b45a7/html5/thumbnails/30.jpg)
Compliance – know where you stand in the context of the industryConsider programs to increase your absolute consent %Consider programs to increase your aggregate consent %Consider programs to increase your nominal consent %
Business – Spend comparison by drug, device, specialty, physician, HCO, etc.Understand your spend end to endMonitor your spend end to endEffectively compare your spend against the industry
Business & Compliance considerations